Hepatic Medicine-Evidence and Research

Scope & Guideline

Unlocking Insights in Hepatic Medicine

Introduction

Immerse yourself in the scholarly insights of Hepatic Medicine-Evidence and Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1179-1535
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationHEPATIC MED-EVID RES / HEPATIC MED.-EVID. RES.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Hepatic Medicine-Evidence and Research' focuses on advancing knowledge in the field of hepatic medicine through rigorous research and evidence-based practices. It encompasses a wide array of topics related to liver diseases, their treatment, and management, with a strong emphasis on clinical outcomes and innovative therapeutic approaches.
  1. Liver Disease Epidemiology and Public Health:
    The journal publishes research on the prevalence, risk factors, and epidemiological trends of liver diseases, including hepatitis and cirrhosis, particularly in diverse geographical contexts.
  2. Innovative Therapeutic Approaches:
    It highlights studies on novel treatment methodologies, including pharmacological therapies, traditional medicine applications, and surgical interventions for liver diseases.
  3. Clinical Outcomes and Prognostic Indicators:
    Research focusing on clinical outcomes, prognostic markers, and patient management strategies in liver disease, particularly in advanced conditions such as hepatocellular carcinoma and cirrhosis.
  4. Impact of Systemic Conditions on Liver Health:
    The journal explores how systemic diseases, including infections like COVID-19 and comorbidities such as HIV, influence liver health and complicate liver disease management.
  5. Patient-Centered Care and Health Guidance:
    It emphasizes the importance of patient involvement in care, showcasing studies on patient-participated healthcare models and their impact on treatment outcomes.
The journal has shown a dynamic evolution in its thematic focus, reflecting emerging trends in hepatic research and clinical practice. These trends indicate a growing interest in innovative methodologies and the intersection of liver health with broader health concerns.
  1. COVID-19 and Liver Interactions:
    Recent publications have increasingly explored the complex interactions between COVID-19 and liver health, including the impact of the virus on liver function and the management of patients with pre-existing liver conditions.
  2. Biomarkers and Predictive Models:
    There is a rising trend in research investigating biomarkers for liver diseases, particularly in predicting disease progression and treatment responses, showcasing the shift towards precision medicine.
  3. Integrative and Traditional Medicine:
    An emerging theme is the exploration of integrative approaches to liver treatment, including the use of traditional medicine and herbal treatments, particularly in specific regional contexts like Ethiopia.
  4. Patient-Participated Care Models:
    The journal is increasingly publishing studies on patient-participated care models, emphasizing the importance of patient involvement in decision-making and care processes, which is vital for improving outcomes in liver disease management.
  5. Innovative Surgical and Therapeutic Techniques:
    Research into novel surgical interventions and therapeutic techniques, such as xenotransplantation and advanced minimally invasive procedures, has gained traction, reflecting ongoing innovation in the field.

Declining or Waning

While 'Hepatic Medicine-Evidence and Research' continues to address a broad range of topics, certain themes have seen a decline in focus over recent years. This may reflect shifts in research priorities or advancements in understanding that have rendered some topics less prominent.
  1. Traditional Diagnostic Techniques:
    There has been a noticeable decrease in studies focusing on traditional liver diagnostic techniques like liver biopsies, as the field shifts towards non-invasive methods and technologies.
  2. Generalized Hepatitis Management:
    Research centered on generalized treatment protocols for hepatitis has declined, possibly due to the increasing focus on personalized medicine and targeted therapies.
  3. Alcohol-Related Liver Disease Studies:
    Although still important, the frequency of publications specifically addressing alcohol-related liver diseases has waned, as more attention is directed toward broader systemic impacts and co-morbidities.

Similar Journals

Clinics in Liver Disease

Exploring the frontiers of liver disease management.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

Frontline Gastroenterology

Pioneering Research for Liver and Gut Health
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

ACTA GASTRO-ENTEROLOGICA BELGICA

Unveiling New Frontiers in Gastrointestinal Health
Publisher: UNIV CATHOLIQUE LOUVAIN-UCLISSN: 1784-3227Frequency: 4 issues/year

ACTA GASTRO-ENTEROLOGICA BELGICA is a prestigious journal dedicated to advancing the field of gastroenterology through the dissemination of high-quality research and clinical insights. Published by UNIVERSITE CATHOLIQUE DE LOUVAIN (UCL), this journal is an essential resource for researchers, healthcare professionals, and students alike, focusing on a wide range of topics including gastrointestinal diseases, treatments, and innovations in clinical practices. While the journal operates under a traditional access model, its impact in the academic community is significant, ensuring that vital research is communicated effectively to stakeholders in Belgium and beyond. With its commitment to academic excellence, ACTA GASTRO-ENTEROLOGICA BELGICA plays a crucial role in fostering high-level discourse and collaboration among experts in the field, ultimately encouraging advancements that improve patient care and outcomes.

ZEITSCHRIFT FUR GASTROENTEROLOGIE

Pioneering Knowledge in Gastroenterology and Beyond
Publisher: GEORG THIEME VERLAG KGISSN: 0044-2771Frequency: 12 issues/year

ZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.

International Journal of Hepatobiliary and Pancreatic Diseases

Connecting Researchers and Clinicians for Global Health Solutions
Publisher: EDORIUM JOURNALSISSN: 2230-9012Frequency: 1 issue/year

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.

Hepatic Oncology

Elevating Research on Hepatic Malignancies
Publisher: FUTURE MEDICINE LTDISSN: 2045-0923Frequency: 4 issues/year

Hepatic Oncology is a premier Open Access journal published by Future Medicine Ltd that specializes in the critical intersection of hepatology and oncology. With a focus on advancing knowledge in the diagnosis and treatment of liver cancers, the journal provides a platform for innovative research, reviews, and clinical perspectives that serve as a valuable resource for researchers, clinicians, and students alike. Established in 2016 and evolving over the years, Hepatic Oncology underscores its commitment to accessible scientific communication, having transitioned to open access in 2018 to reach a broader audience. The journal holds a Q4 quartile ranking in the fields of hepatology and oncology for 2023, reflecting its emerging influence and role in contemporary research. Through high-quality articles and a focus on real-world applications, Hepatic Oncology aims to bridge gaps in knowledge while fostering collaboration among professionals dedicated to enhancing patient care in hepatic malignancies.

Clinical and Molecular Hepatology

Bridging clinical practice and molecular discoveries in liver health.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Gastroenterology Insights

Connecting Researchers to Shape Gastroenterology's Future
Publisher: MDPIISSN: 2036-7414Frequency: 4 issues/year

Gastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.

BMJ Open Gastroenterology

Leading the Way in Innovative Gastroenterological Research
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Gastroenterologia y Hepatologia

Fostering innovation in the diagnosis and treatment of liver diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.